<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>5(5)</volume><submitter>Dempke WC</submitter><journal>Translational lung cancer research</journal><pagination>538-542</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5099520</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer?</pubmed_title><pmcid>PMC5099520</pmcid><pubmed_authors>Dempke WC</pubmed_authors><pubmed_authors>Fenchel K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Pembrolizumab as first-line treatment for non-small cell lung cancer-a game changer?</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Oct</publication><modification>2025-04-26T21:19:55.305Z</modification><creation>2025-04-06T16:45:12.297Z</creation></dates><accession>S-EPMC5099520</accession><cross_references><pubmed>27826536</pubmed><doi>10.21037/tlcr.2016.10.01</doi></cross_references></HashMap>